СОВРЕМЕННОЕ СОСТОЯНИЕ ПРОБЛЕМЫ ЖЕНСКОЙ ФЕРТИЛЬНОСТИ ПРИ ОНКОЛОГИЧЕСКИХ ЗАБОЛЕВАНИЯХ И СНИЖЕНИИ ОВАРИАЛЬНОГО РЕЗЕРВА

Cover Page

Cite item

Full Text

About the authors

Военно-медицинская академия им. С.М. Кирова, г. Санкт-Петербург

Author for correspondence.
Email: Kharkevich.olga@mail.ru
Начальник кафедры и клиники акушерства и гинекологии ФГБВОУ ВО "Военно-медицинская академия имени С.М.Кирова", к.м.н., доцент Russian Federation

Военно-медицинская академия им. С.М. Кирова, г. Санкт-Петербург

Email: Kharkevich.olga@mail.ru
Профессор кафедры и клиники акушерства и гинекологии ФГБВОУ ВО "Военно-медицинская академия имени С.М.Кирова", д.м.н., профессор Russian Federation

Военно-медицинская академия им. С.М. Кирова, г. Санкт-Петербург

Email: Kharkevich.olga@mail.ru
Профессор кафедры и клиники акушерства и гинекологии ФГБВОУ ВО "Военно-медицинская академия имени С.М.Кирова", д.м.н., профессор Russian Federation

Военно-медицинская академия им. С.М. Кирова, г. Санкт-Петербург

Email: terrestra@mail.ru
Старший научный сотрудник НИЛ (тканевой инженерии) НИО (медико-биологических исследований) НИЦ ФГБВОУ ВО  "Военно-медицинская академия имени С.М.Кирова", д.м.н., доцент Russian Federation

Военно-медицинская академия им. С.М. Кирова, г. Санкт-Петербург

Email: terrestra@mail.ru
Старший научный сотрудник НИЛ (тканевой инженерии) НИО (медико-биологических исследований) НИЦ ФГБВОУ ВО  "Военно-медицинская академия имени С.М.Кирова", д.м.н., доцент Russian Federation

References

  1. Гамзатова З.Х., Комличенко Э.В., Костарева А.А., Галагудза М.М., Берлев И.В., Урманчеева А.Ф., Ульрих Е.А., Малашичева А.Б., Белякова М.В., Молоткова М.Ю. Возможности криоконсервации овариальной ткани у онкологических больных // Вопросы онкологии. 2015. Т. 61. № 2: 199 – 204. [Gamzatova Z.H., Komlichenko E.V., Kostareva A.A., Galagudza M.M., Berlev I.V., Urmancheeva A.F., Ul'rih E.A., Malashicheva A.B., Belyakova M.V., Molotkova M.YU. Vozmozhnosti kriokonservacii ovarial'noj tkani u onkologicheskih bol'nyh. Voprosy onkologii. 2015. T. 61. № 2: 199-204 (in Russ.)].
  2. Курочкина Д.Н., Кулева С.А. Фертильность взрослых, излеченных в детском возрасте от лимфомы Ходжкина // Проблемы репродукции. 2018. Т. 24. № 4: 22 – 27. [Kurochkina D.N., Kuleva S.A. Fertil'nost' vzroslyh, izlechennyh v detskom vozraste ot limfomy Hodzhkina. Problemy reprodukcii. 2018; T. 24, № 4: 22-27. (in Russ.)].
  3. De Vos M., Smitz J., Woodruff T.K. Fertility preservation in women with cancer // Lancet. 2014. 384:1302 – 1310.
  4. Demeestere I., Simon P., Dedeken L. et al. Live birth after autograft of ovarian tissue cryopreserved during childhood // Hum Reprod. 2015; 30:2107 – 2109.
  5. Walsh F. Woman has baby using ovary frozen in childhood. Available at:http://www.bbc.com/news/health-38312995(accessed 25.05.2019).
  6. Ito Y., Miyashiro I., Ito H. et al. Long‐term survival and conditional survival of cancer patients in Japan using population based cancer registry data // Cancer Sci. 2014. 105:1480 –1486.
  7. Takai Y. Recent advances in oncofertility care worldwide and in Japan // Reprod Med Biol. 2018. 17(4):356 – 368.
  8. Gosden R.G., Baird D.T. et al. Restoration of fertility to oophorectomized sheep by ovarian autografts stored at –196 degrees C // Hum Reprod. 1994. 9(4):597–603.
  9. Huang J.Y., Tulandi T., Holzer H., Tan S.L., Chian R.C. Combining ovarian tissue cryobanking with retrieval of immature oocytes followed by in vitro maturation and vitrification: an additional strategy of fertility preservation // Fertil Steril. 2008. 89:567 – 572.
  10. White Y.A., Woods D.C., Takai Y., Ishihara O., Seki H., Tilly J.L. Oocyte formation by mitotically active germ cells purified from ovaries of reproductive age women // Nat Med. 2012. 18:413 – 421.
  11. Prasath E.B., Chan M.L., Wong W.H. et al. First pregnancy and live birth resulting from cryopreserved embryos obtained from in vitro matured oocytes after oophorectomy in an ovarian cancer patient // Hum Reprod. 2014. 29:276 – 278.
  12. Silvestris E., Cafforio P., D'Oronzo S., Felici C., Silvestris F., Loverro G. In vitro differentiation of human oocyte‐like cells from oogonial stem cells: single‐cell isolation and molecular characterization // Hum Reprod. 2018. 33:464‐473.
  13. Silber S.J., DeRosa M. et al. A series of monozygotic twins discordant for ovarian failure: ovary transplantation (cortical versus microvascular) and cryopreservation // Hum Reprod. 2008. 23(7):1531 – 1537.
  14. Silber S.J., Gosden R.G. Ovarian transplantation in a series of monozygotic twins discordant for ovarian failure // N Engl J Med. 2007. 356(13):1382 – 1384.
  15. Silber S.J., Grudzinskas G., et al. Successful pregnancy after microsurgical transplantation of an intact ovary // N Engl J Med. 2008. 359(24):2617 – 2618.
  16. Silber S.J., Lenahan K.M. et al. Ovarian transplantation between monozygotic twins discordant for premature ovarian failure // N Engl J Med. 2005. 353(1):58–63.
  17. Huober–Zeeb C., Lawrenz B., Popovici R.M. et al. Improving fertility preservation in cancer: ovarian tissue cryobanking followed by ovarian stimulation can be efficiently combined // Fertil Steril. 2011. 95:342 – 344.
  18. Moore H.C., Unger J.M., Phillips K.A. et al. Goserelin for ovarian protection during breast cancer adjuvant chemotherapy // N Engl J Med. 2015. 372:923 – 932.
  19. Demeestere I., Brice P., Peccatori F.A. et al. No evidence for the benefit of gonadotropin-releasing hormone agonist in preserving ovarian function and fertility in lymphoma survivors treated with chemotherapy: final long-term report of a prospective randomized trial // J Clin Oncol. 2016. 34:2568 – 2574.
  20. Roness H., Kalich-Philosoph L., Meirow D. Prevention of chemotherapy-induced ovarian damage: possible roles for hormonal and non-hormonal attenuating agents // Hum Reprod Update. 2014. 20:759 – 774.
  21. Loren A.W., Mangu P.B., Beck L.N., et al. Fertility preservation for patients with cancer: American Society of Clinical Oncology clinical practice guideline update // J Clin Oncol. 2013. 31:2500 – 2510.
  22. Cobo A., Garcia-Velasco J.A., Coello A., Domingo J., Pellicer A., Remohi J. Oocyte vitrification as an efficient option for elective fertility preservation // Fertil Steril. 2016. 105:755 – 764.
  23. von Wolff M., Montag M., Dittrich R., Denschlag D., Nawroth F., Lawrenz B. Fertility preservation in women – a practical guide to preservation techniques and therapeutic strategies in breast cancer, Hodgkin's lymphoma and borderline ovarian tumours by the fertility preservation network FertiPROTEKT // Arch Gynecol Obstet. 2011. 284:427 – 435.
  24. Germeyer A. SOCIAL FREEZING und die vereinbarkeit von beruf und familie. Available at: https://static1.squarespace.com/static/560a328fe4b0e8c4f373857e/t/57206c853c44d81ea19e790b/1461742728020/registerdaten_fertiprotekt_2015.pdf (accessed 06.01.2019).
  25. Practice Committees of American Society for Reproductive Medicine, Society for Assisted Reproductive Technology. Mature oocyte cryopreservation: a guideline // Fertil Steril. 2013. 99:37 – 43.
  26. Practice Committee of American Society for Reproductive Medicine. Ovarian tissue cryopreservation: a committee opinion // Fertil Steril. 2014. 101:1237 – 1243.
  27. National Institute for Health and Clinical Excellence. Fertility problems: assessment and treatment. Available at:http://www.nice.org.uk/guidance/cg156 (accessed 25.05.2019).
  28. Japan Society for Fertility Preservation (ed). Treatment selection and patient support program for supporting and maintaining fertility in breast cancer patients. When breast cancer patients have a desire to bear children in the future, is communication between cancer treatment specialists and reproductive care specialists recommended? / Handbook on Pregnancy, Birth, and Fertility Treatment for Breast Cancer Patients. Tokyo: Kanehara & Company, Ltd. 2014. 14 – 16.
  29. Japan Society for Reproductive Medicine. A guideline of oocyte and ovarian tissue cryopreservation for medical indications. Available at: http://www.jsrm.or.jp/guideline-statem/guideline_2013_01.pdf (accessed 25.05.2019).
  30. Japan Society of Obstetrics and Gynecology. A statement on oocyte, embryo and ovarian tissue cryopreservation for medical indications. Available at: http://www.jsog.or.jp/ethic/mijyuseiranshi_20160625.html (accessed 25.05.2019).
  31. Киселева М.В., Комарова Е.В., Малинова И.В., Карпейкина М.М., Денисов М.С. Восстановление фертильности у онкологических больных методом ретрансплантации витрифицированной ткани яичника // Репродуктивная медицина. 2013. № 3-4 (16): 33 – 35. [Kiseleva M.V., Komarova E.V., Malinova I.V., Karpejkina M.M., Denisov M.S. Vosstanovlenie fertil'nosti u onkologicheskih bol'nyh metodom retransplantacii vitrificirovanno tkani yaichnika // Reproduktivnaya medicina. 2013. № 3-4 (16): 33-35 (in Russ.)].
  32. Рухляда Н.Н., Мотовилова Н.О., Грязнов А.Ю., Бирюкова Е.И., Гасымова Д.М., Мельникова М.А.Перспективы и первые результаты аутотрансплантации ткани яичника // Проблемы репродукции. 2013. Т. 19. № 2: 48 – 51. [Ruhlyada N.N., Motovilova N.O., Gryaznov A.YU., Biryukova E.I., Gasymova D.M., Mel'nikova M.A. Perspektivy i pervye rezul'taty autotransplantacii tkani yaichnika // Problemy reprodukcii. 2013.T. 19 № 2: 48-51 (in Russ.)].
  33. Способ подготовки ткани яичника к трансплантации у пациенток со злокачественными новообразованиями органов репродуктивной системы: патент на изобретение RU 2336697 (дата начала отсчёта действия патента – 20.07.2007) / Быстрова О.В. // Бюллетень Федеральной службы интеллектуальной собственности РФ № 30 от 27.10.2008. [Sposob podgotovki tkani yaichnika k transplantacii u pacientok so zlokachestvennymi novoobrazovaniyami organov reproduktivnoj sistemy: patent na izobretenie RU 2336697 (data nachala otschyota dejstviya patenta – 20.07.2007) / Bystrova O.V. // Byulleten' Federal'noj sluzhby intellektual'noj sobstvennosti RF № 30 ot 27.10.2008. (in Russ.)].
  34. Способ восстановления фертильности у пациенток с онкологическими заболеваниями: патент на изобретение RU 2519637 (дата начала отсчёта действия патента – 20.12.2012) / Цыб А.Ф., Киселева М.В., Карпейкина М.М., Комарова Е.В., Малинова И.В. // Бюллетень Федеральной службы интеллектуальной собственности РФ № 17 от 20.06.2014. [Sposob vosstanovleniya fertil'nosti u pacientok s onkologicheskimi zabolevaniyami: patent na izobretenie RU 2519637 (data nachala otschyota dejstviya patenta – 20.12.2012) / Cyb A.F., Kiseleva M.V., Karpejkina M.M., Komarova E.V., Malinova I.V. // Byulleten' Federal'noj sluzhby intellektual'noj sobstvennosti RF № 17 ot 20.06.2014. (in Russ.)].
  35. Курцер М.А. Предективные технологии и возможности молекулярной генетики в репродуктивной медицине // Вестник Российской академии наук. 2017. Т. 87. № 8: 689-695. [Kurcer M.A. Predektivnye tekhnologii i vozmozhnosti molekulyarnoj genetiki v reproduktivnoj medicine. Vestnik Rossijskoj akademii nauk. 2017; T. 87, № 8: 689-695.(in Russ.)].
  36. Диникина Ю.В., Белогурова М.Б., Первунина Т.М., Комличенко Э.В. Криоконсервация ткани яичника у девочек с онкологической патологией: мультидисциплинарная программа / Современные проблемы подростковой медицины и репродуктивного здоровья молодежи. Кротинские чтения // Сборник трудов 2-й Всероссийской научно-практической конференции. Санкт-Петербург; 2018: 365 – 366. [Dinikina YU.V., Belogurova M.B., Pervunina T.M., Komlichenko EH.V.Kriokonservaciya tkani yaichnika u devochek s onkologicheskoj patologiej: mul'tidisciplinarnaya programma / Sovremennye problemy podrostkovoj mediciny i reproduktivnogo zdorov'ya molodezhi. Krotinskie chteniya // Sbornik trudov 2-j Vserossijskoj nauchno-prakticheskoj konferencii. Sankt-Peterburg; 2018.: 365-366 (in Russ.)].
  37. Киселева М.В., Малинова И.В., Комарова Е.В., Шведова Т.И., Денисов М.С., Каприн А.Д. Первая в России беременность после ортотопической трансплантации витрифицированной овариальной ткани // Исследования и практика в медицине. 2015. Т. 2. № S1: 24.
  38. Лапина Е.Н., Быстрова О.В., Калугина А.С., Лисянская А.С., Татищева Ю.А., Тапильская Н.И., Манихас Г.М. Первая беременность в России после трансплантации криоконсервированной ткани яичника пациентке с лимфомой Ходжкина (описание случая) // Проблемы репродукции. 2015. 21(3): 63-67. [Lapina E.N., Bystrova O.V., Kalugina A.S., Lisyanskaya A.S., Tatishcheva Yu.A., Tapil'skaya N.I., Manihas G.M. Pervaya beremennost' v Rossii posle transplantacii kriokonservirovannoj tkani yaichnika pacientke s limfomoj Hodzhkina (opisanie sluchaya) // Problemy reprodukcii. 2015. 21(3): 63-67 (in Russ.)].
  39. Yu K.D., Huang S., Zhang J.X., Liu G.Y., Shao Z.M. Association between delayed initiation of adjuvant CMF or anthracycline-based chemotherapy and survival in breast cancer: a systematic review and meta-analysis // BMC Cancer. 2013. 13:240.
  40. Smith E.C., Ziogas A., Anton-Culver H. Delay in surgical treatment and survival after breast cancer diagnosis in young women by race/ethnicity // JAMA Surg. 2013. 148:516 – 523.
  41. Barekati Z., Gourabi H., Valojerdi M.R., Yazdi P.E. Previous maternal chemotherapy by cyclophosphamide (Cp) causes numerical chromosome abnormalities in preimplantation mouse embryos // Reprod Toxicol. 2008. 26:278 – 281.
  42. Kato O., Kawasaki N., Bodri D., et al. Neonatal outcome and birth defects in 6623 singletons born following minimal ovarian stimulation and vitrified versus fresh single embryo transfer // Eur J Obstet Gynecol Reprod Biol. 2012; 161:46 – 50.
  43. Karimzadeh M.A., Ahmadi S., Oskouian H., Rahmani E. Comparison of mild stimulation and conventional stimulation in ART outcome // Arch Gynecol Obstet. 2010. 281:741 – 746.
  44. Grynberg M., Poulain M., le Parco S., Sifer C., Fanchin R., Frydman N. Similar in vitro maturation rates of oocytes retrieved during the follicular or luteal phase offer flexible options for urgent fertility preservation in breast cancer patients // Hum Reprod. 2016. 31:623 – 629.
  45. Kuang Y., Chen Q., Hong Q. et al. Double stimulations during the follicular and luteal phases of poor responders in IVF/ICSI programmes (Shanghai protocol) // Reprod Biomed Online. 2014. 29:684 – 691.
  46. Tatsumi T., Jwa S.C., Kuwahara A., Irahara M., Kubota T., Saito H. No increased risk of major congenital anomalies or adverse pregnancy or neonatal outcomes following letrozole use in assisted reproductive technology // Hum Reprod. 2017. 32:125 – 132.
  47. Turan V., Bedoschi G., Moy F., Oktay K. Safety and feasibility of performing two consecutive ovarian stimulation cycles with the use of letrozole-gonadotropin protocol for fertility preservation in breast cancer patients // Fertil Steril. 2013. 100:1681 – 1685.
  48. Noyes N., Porcu E., Borini A. Over 900 oocyte cryopreservation babies born with no apparent increase in congenital anomalies // Reprod Biomed Online. 2009. 18:769 – 776.
  49. Pinborg A., Wennerholm U.B., Romundstad L.B. et al. Why do singletons conceived after assisted reproduction technology have adverse perinatal outcome? Systematic review and meta-analysis // Hum Reprod Update. 2013. 19:87 – 104.
  50. Maheshwari A., Pandey S., Shetty A., Hamilton M., Bhattacharya S. Obstetric and perinatal outcomes in singleton pregnancies resulting from the transfer of frozen thawed versus fresh embryos generated through in vitro fertilization treatment: a systematic review and meta-analysis // Fertil Steril. 2012 98:368 – 377.
  51. Nakashima A., Araki R., Tani H., et al. Implications of assisted reproductive technologies on term singleton birth weight: an analysis of 25777 children in the national assisted reproduction registry of Japan // Fertil Steril. 2013. 99:450 – 455.
  52. Ishihara O., Araki R., Kuwahara A., Itakura A., Saito H., Adamson G.D. Impact of frozen-thawed single-blastocyst transfer on maternal and neonatal outcome: an analysis of 277,042 single-embryo transfer cycles from 2008 to 2010 in Japan // Fertil Steril. 2014. 101:128 – 133.
  53. Molina I., Mari M., Martinez J.V., Novella-Maestre E., Pellicer N., Peman J. Bacterial and fungal contamination risks in human oocyte and embryo cryopreservation: open versus closed vitrification systems // Fertil Steril. 2016. 106:127 – 132.
  54. Papatheodorou A., Vanderzwalmen P., Panagiotidis Y. et al. Open versus closed oocyte vitrification system: a prospective randomized sibling-oocyte study // Reprod Biomed Online. 2013. 26:595 – 602.
  55. Smith G.D., Serafini P.C., Fioravanti J. et al. Prospective randomized comparison of human oocyte cryopreservation with slow-rate freezing or vitrification // Fertil Steril. 2010. 94:2088 – 2989.
  56. Donnez J., Dolmans M.M. Fertility preservation in women // N Engl J Med. 2017. 377:1657 – 1665.
  57. Kagawa N., Silber S., Kuwayama M. Successful vitrification of bovine and human ovarian tissue // Reprod Biomed Online. 2009. 18:568 – 577.
  58. Suzuki N. Oncofertility in Japan: advances in research and the roles of oncofertility consortia // Future Oncol. 2016. 12:2307 – 2311.
  59. Shi Q., Xie Y., Wang Y., Li S. Vitrification versus slow freezing for human ovarian tissue cryopreservation: a systematic review and meta-anlaysis // Sci Rep. 2017. 7:8538.
  60. Nakamura Y., Obata R., Okuyama N., Aono N., Hashimoto T., Kyono K. Residual ethylene glycol and dimethyl sulphoxide concentration in human ovarian tissue during warming/thawing steps following cryopreservation // Reprod Biomed Online. 2017. 35:311 – 313.
  61. Kawamura K., Cheng Y., Suzuki N. et al. Hippo signaling disruption and Akt stimulation of ovarian follicles for infertility treatment // Proc Natl AcadSci USA. 2013. 110:17474 – 17479.
  62. Багненко С.Ф., Афанасьев Б.В., Беженарь В.Ф., Рухляда Н.Н. Перспективы применения криоконсервирующих технологий сохранения фертильности у женщин // Исследования и практика в медицине. 2015. 2.S1: 29. [Bagnenko S.F., Afanas'ev B.V., Bezhenar' V.F., Ruhlyada N.N. Perspektivy primeneniya kriokonserviruyushchih tekhnologij sohraneniya fertil'nosti u zhenshchin // Issledovaniya i praktika v medicine. 2015. 2.S1: 29. (in Russ.)].
  63. Jensen A.K., Macklon K.T., Fedder J., Ernst E., Humaidan P., Andersen C.Y. 86 successful births and 9 ongoing pregnancies worldwide in women transplanted with frozen-thawed ovarian tissue: focus on birth and perinatal outcome in 40 of these children // J Assist Reprod Genet. 2017. 34:325 – 336.
  64. Stern C.J., Gook D., Hale L.G. et al. Delivery of twins following heterotopic grafting of frozen-thawed ovarian tissue // Hum Reprod. 2014. 29:1828.
  65. Meirow D., Levron J., Eldar-Geva T. et al. Pregnancy after transplantation of cryopreserved ovarian tissue in a patient with ovarian failure after chemotherapy // N Engl J Med. 2005. 353:318 – 321.
  66. Van der Ven H., Liebenthron J., Beckmann M. et al. Ninetyfive orthotopic transplantations in 74 women of ovarian tissue after cytotoxic treatment in a fertility preservation network: tissue activity, pregnancy and delivery rates // Hum Reprod. 2016. 31:2031 – 2041.
  67. Silber S. Ovarian tissue cryopreservation and transplantation: scientific implications // J Assist Reprod Genet. 2016. 33:1595 – 1603.
  68. Andersen C.Y., Rosendahl M., Byskov A.G. et al. Two successful pregnancies following autotransplantation of frozen/thawed ovarian tissue // Hum Reprod. 2008. 23:2266 – 2272.
  69. Dittrich R., Lotz L., Keck G., et al. Live birth after ovarian tissue autotransplantation following overnight transportation before cryopreservation // Fertil Steril. 2012. 97:387 – 390.
  70. Soleimani R., Heytens E., Oktay K. Enhancement of neoangiogenesis and follicle survival by sphingosine-1-phosphate in human ovarian tissue xenotransplants // PLoSONE. 2011. 6:e19475.
  71. Telfer E.E., McLaughlin M. In vitro development of ovarian follicles // Semin Reprod Med. 2011. 29:15 – 23.
  72. McLaughlin M., Albertini D.F., Wallace W.H.B., Anderson R.A., Telfer E.E. Metaphase II oocytes from human unilaminar follicles grown in a multi-step culture system // Mol Hum Reprod. 2018. 24:135 – 142.
  73. Johnson J., Canning J., Kaneko T., Pru J.K., Tilly J.L. Germline stem cells and follicular renewal in the postnatal mammalian ovary // Nature. 2004. 428:145 – 150.
  74. Zou K., Yuan Z., Yang Z. et al. Production of offspring from a germline stem cell line derived from neonatal ovaries // Nat Cell Biol. 2009. 11:631 – 636.
  75. Zhang H., Panula S., Petropoulos S. et al. Adult human and mouse ovaries lack DDX4-expressing functional oogonial stem cells // Nat Med. 2015. 21:1116 – 1118.
  76. Zhang H., Zheng W., Shen Y., Adhikari D., Ueno H., Liu K. Experimental evidence showing that no mitotically active female germline progenitors exist in postnatal mouse ovaries // Proc Nat Acad Sci U S A. 2012. 109:12580 – 12585.
  77. Ministry of Education Culture Sports Science and Technology. Guidelines on the Research on Producing Germ Cells from Human iPS Cells or Human Tissue Stem Cells. 2010. Available at: http://www.lifescience.mext.go.jp/files/pdf/n1567_02r2.pdf (accessed 25.05.2019).
  78. Van Eyck A.S., Jordan B.F., Gallez B., Heilier J.F., Van Langendonckt A., Donnez J. Electron paramagnetic resonance as a tool to evaluate human ovarian tissue reoxygenation after xenografting // Fertil Steril. 2009. 92:374 – 381.
  79. Ayuandari S., Winkler-Crepaz K., Paulitsch M. et al. Follicular growth after xenotransplantation of cryopreserved/thawed human ovarian tissue in SCID mice: dynamics and molecular aspects // J Assist Reprod Genet. 2016. 33:15851593.
  80. Gavish Z., Spector I., Peer G. et al. Follicle activation is a significant and immediate cause of follicle loss after ovarian tissue transplantation // J Assist Reprod Genet. 2017. 35:61 – 69.
  81. Demeestere I., Simon P., Emiliani S., Delbaere A., Englert Y. Orthotopic and heterotopic ovarian tissue transplantation // Hum Reprod Update. 2009. 15:649 – 665.
  82. Kang B.J., Wang Y., Zhang L., Xiao Z., Li S.W. bFGF and VEGF improve the quality of vitrified-thawed human ovarian tissues after xenotransplantation to SCID mice // J Assist Reprod Genet. 2016. 33:281 – 289.
  83. Kong H.S., Lee J., Youm H.W. et al. Effect of treatment with angiopoietin‐2 and vascular endothelial growth factor on the quality of xenografted bovine ovarian tissue in mice // PLoSONE. 2017. 12:0184546.
  84. Man L., Park L., Bodine R. et al. Engineered endothelium provides angiogenic and paracrine stimulus to grafted human ovarian tissue // Sci Rep. 2017. 7:8203.
  85. Oktay K., Bedoschi G., Pacheco F., Turan V., Emirdar V. First pregnancies, live birth, and in vitro fertilization outcomes after transplantation of frozen-banked ovarian tissue with a human extracellular matrix scaffold using robot-assisted minimally invasive surgery // Am J Obstet Gynecol. 2016. 214(e1 – 94):e9.
  86. Shikanov A., Zhang Z., Xu M. et al. Fibrin encapsulation and vascular endothelial growth factor delivery promotes ovarian graft survival in mice // Tissue Eng Part A. 2011. 17:3095 – 3104.
  87. Rosendahl M., Greve T., Andersen C.Y. The safety of transplanting cryopreserved ovarian tissue in cancer patients: a review of the literature // J Assist Reprod Genet. 2013. 30:11 – 24.
  88. Balduzzi A., Dalle J.H., Jahnukainen K. et al. Fertility preservation issues in pediatric hematopoietic stem cell transplantation: practical approaches from the consensus of the Pediatric Diseases Working Party of the EBMT and the International BFM Study Group // Bone Marrow Transplant. 2017. 52:1406 – 1415.
  89. Shapira M., Raanani H., Barshack I. et al. First delivery in a leukemia survivor after transplantation of cryopreserved ovarian tissue, evaluated for leukemia cells contamination // Fertil Steril. 2017. 109:48 – 53.
  90. Ito Y., Shiraishi E., Kato A. et al. The utility of decision trees in oncofertility care in Japan // J Adolesc Young Adult Oncol. 2017. 6:186 – 189.
  91. Scott-Trainer J. The role of a patient navigator in fertility preservation // Cancer Treat Res. 2010. 156:469 – 470.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c)


 


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies